Psychosocial factors associated with the risk of developing psychosis in a Mexican general population sample.

Epidemiological evidence has linked an array of sociodemographic and psychosocial factors with an increased risk of developing psychosis. However, research in samples from low- and middle-income countries is still scarce. This study used a Mexican sample to explore (i) sociodemographic and psychosocial differences between individuals with and without a positive screen for Clinical High-Risk for psychosis (CHR), and (ii) sociodemographic and psychosocial factors associated with screening positive for CHR. The sample consisted of 822 individuals from the general population who completed an online survey. Of the participants, 17.3% (n = 142) met the CHR screening criteria. Comparisons between those who screened positive (CHR-positive group) and those who did not (Non-CHR group) showed that participants in the CHR-positive group were younger, had a lower educational level, and reported more mental health problems than the Non-CHR group. Furthermore, relative to the Non-CHR group, the CHR-positive group had a greater prevalence of medium/high risk associated with cannabis use, a higher prevalence of adverse experiences (bullying, intimate partner violence, and experiencing a violent or unexpected death of a relative or friend), as well as higher levels of childhood maltreatment, poorer family functioning, and more distress associated with the COVID-19 pandemic. Groups did not differ in sex, marital/relationship status, occupation, and socio-economic status. Finally, when examined in multivariate analyses, the variables associated with screening positive for CHR were: having an unhealthy family functioning (OR = 2.75, 95%CI 1.69-4.46), a higher risk associated with cannabis use (OR = 2.75, 95%CI 1.63-4.64), a lower level of education (OR = 1.55, 95%CI 1.003-2.54), having experienced a major natural disaster (OR = 1.94, 95%CI 1.18-3.16), having experienced a violent or unexpected death of a relative or friend (OR = 1.85, 95%CI 1.22-2.81), higher levels of childhood emotional abuse (OR = 1.88, 95%CI 1.09-3.25), physical neglect (OR = 1.68, 95%CI 1.08-2.61), and physical abuse (OR = 1.66, 95%CI 1.05-2.61), and higher COVID-related distress (OR = 1.10, 95%CI 1.01-1.20). An older age was a protective factor for screening positive for CHR (OR = 0.96, 95%CI 0.92-0.99). Overall, the findings highlight the importance of examining potential psychosocial contributors to psychosis vulnerability across different sociocultural contexts to delineate risk and protective processes relevant to specific populations and better target preventive intervention efforts.

Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics.

Atypical antipsychotics (AAP) or second-generation antipsychotics are the clinical option for schizophrenia treatment during acute psychoses, but they are also indicated for maintenance during lifetime, even though they are being used for other psychiatric conditions in clinical practice such as affective disorders and autism spectrum disorder, among others. These drugs are differentiated from typical antipsychotics based on their clinical profile and are a better choice because they cause fewer side effects regarding extrapyramidal symptoms (EPS). Even though they provide clear therapeutic benefits, AAP induce peripheral effects that trigger phenotypic, functional, and systemic changes outside the Central Nervous System (CNS). Metabolic disease is frequently associated with AAP and significantly impacts the patient's quality of life. However, other peripheral changes of clinical relevance are present during AAP treatment, such as alterations in the immune and endocrine systems as well as the intestinal microbiome. These less studied alterations also have a significant impact in the patient's health status. This manuscript aims to revise the peripheral immunological, endocrine, and intestinal microbiome changes induced by AAP consumption recommended in the clinical guidelines for schizophrenia and other psychiatric disorders.

Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome.

BACKGROUND: New approaches to assess outcome in schizophrenia include multidimensional measures such as remission, cognition, psychosocial functioning, and quality of life. Clinical and psychosocial measures have been recently introduced to assess functional outcome. OBJECTIVE: The study presented here was designed to examine the rates of symptomatic remission, psychosocial remission, global functioning, and clinical global impressions in a sample of schizophrenia outpatients in order to assess functional remission and to identify predictive factors for functional remission. METHODS: A total of 168 consecutive Mexican outpatients receiving pharmacological treatment at the National Institute of Psychiatry in Mexico City were enrolled in a cross-sectional study. Symptomatic remission was assessed according to the definition and criteria proposed by the Remission in Schizophrenia Working Group using the Positive and Negative Symptom Scale. Psychosocial remission was assessed according to Barak criteria using the Psychosocial Remission in Schizophrenia scale. Functioning was measured with the Global Assessment of Functioning, and clinical outcome with the Clinical Global Impressions (CGI) Scale. RESULTS: Findings showed that 45.2% of patients fulfilled the symptomatic remission criteria, 32.1% achieved psychosocial remission, and 53% reported adequate functioning. However, the combination of these three outcome criteria - symptomatic, psychosocial remission, and functioning - indicated that 14.9% of the patients achieved our predefined functional remission outcome. The logistic regression model included five predictive variables for functional remission: (1) being employed, (2) use of atypical antipsychotics, (3) lower number of medications, (4) lower negative symptom severity, and (5) lower excitement symptom severity. CONCLUSION: The study demonstrated that symptomatic remission, psychosocial remission, and functioning could be achievable goals for a considerable number of patients. The outcome of functional remission was achieved by a minority of patients, less than 15%. New approaches should include multidimensional measures to assess functional outcome in schizophrenia research.

Association study between the MDR1 gene and clinical characteristics in schizophrenia.

OBJECTIVE: Schizophrenia is a complex psychiatric disorder, characterized by disturbed patterns of thought and affecting 0.3-2.0% of the world population. Previously, the multidrug resistance 1 (MDR1) gene has been associated with schizophrenia in treatment response studies in psychotic patients. The aim of this study was to determine the association between MDR1 gene polymorphisms and clinical characteristics in patients with schizophrenia. METHODS: Positive and negative symptoms of schizophrenia were assessed with the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS) in 158 Mexican patients with schizophrenia. Analyses of MDR1 gene polymorphisms were performed using TaqMan technology. A multivariate ANOVA was performed with MDR1 polymorphisms and gender as independent variables. RESULTS: Males with the G/G genotype of MDR1 rs2032582 presented significantly higher levels of delusions (p = 0.02). When comparing female vs. male groups, the difference was statistically significant (p = 0.0003). Analyses of the MDR1 gene rs1045642 variant showed no significant differences. CONCLUSION: Our findings suggest that male carriers of the G allele of variant rs2032582 exhibit greater severity of delusions; however, these results should be taken as preliminary, and replication studies in other populations of different ethnic origins are required to confirm these findings.

Monoamine oxidase a and B gene polymorphisms and negative and positive symptoms in schizophrenia.

Given that schizophrenia is a heterogeneous disorder, the analysis of clinical characteristics could help to identify homogeneous phenotypes that may be of relevance in genetic studies. Linkage and association studies have suggested that a locus predisposing to schizophrenia may reside within Xp11. We analyzed uVNTR and rs1137070, polymorphisms from MAOA and rs1799836 of MAOB genes to perform single SNP case-control association study in a sample of 344 schizophrenia patients and 124 control subjects. Single polymorphism analysis of uVNTR, rs1137070 and rs1799836 SNPs did not show statistical differences between cases and controls. Multivariate ANOVA analysis of clinical characteristics showed statistical differences between MAOB/rs1799836 and affective flattening scores (F = 4.852, P = 0.009), and significant association between MAOA/uVNTR and affective flattening in female schizophrenia patients (F = 4.236, P = 0.016) after Bonferroni's correction. Our preliminary findings could suggest that severity of affective flattening may be associated by modifier variants of MAOA and MAOB genes in female Mexican patients with schizophrenia. However, further large-scale studies using quantitative symptom-based phenotypes and several candidate variants should be analyzed to obtain a final conclusion.

Application in Mexico of psychosocial rehabilitation with schizophrenia patients.

To determine whether evidence-based, psychosocial treatments developed in the United States and England are applicable to Mexican outpatients with schizophrenia, the present study was carried out to evaluate the relative effectiveness of family psycho-education and psychosocial skills training added to customary treatment vs. customary treatment alone. Clinically stable outpatients with schizophrenia participated in a 12-month randomized, controlled trial at the National Institute of Psychiatry in Mexico City. An experimental group (N = 47) received the combination of psychosocial skills training, family psycho-education and customary pharmacotherapy while the comparison group (N = 36) received customary treatment alone. Patients were assessed at baseline and one year after commencement of treatment. Significant differences favoring the group that received psychosocial rehabilitation were found in ratings of adherence to medication, attendance at appointments, symptoms, social functioning, relapse, and re-hospitalization. While some adaptations were made in the psychosocial treatments to resolve cultural differences, the results provide cross-national validation of evidence-based treatments for persons with schizophrenia.

Association study between the MDR1 gene and clinical characteristics in schizophrenia

Objective: Schizophrenia is a complex psychiatric disorder, characterized by disturbed patterns of thought and affecting 0.3-2.0% of the world population. Previously, the multidrug resistance 1 (MDR1) gene has been associated with schizophrenia in treatment response studies in psychotic patients. The aim of this study was to determine the association between MDR1 gene polymorphisms and clinical characteristics in patients with schizophrenia. Methods: Positive and negative symptoms of schizophrenia were assessed with the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS) in 158 Mexican patients with schizophrenia. Analyses of MDR1 gene polymorphisms were performed using TaqMan technology. A multivariate ANOVA was performed with MDR1 polymorphisms and gender as independent variables. Results: Males with the G/G genotype of MDR1 rs2032582 presented significantly higher levels of delusions (p = 0.02). When comparing female vs. male groups, the difference was statistically significant (p = 0.0003). Analyses of the MDR1 gene rs1045642 variant showed no significant differences. Conclusion: Our findings suggest that male carriers of the G allele of variant rs2032582 exhibit greater severity of delusions; however, these results should be taken as preliminary, and replication studies in other populations of different ethnic origins are required to confirm these findings. .

Recognition of facial expression of the emotions and their relation to attachment styles and psychiatric symptoms: Preliminary study on Psychiatric Residents / Reconocimiento de la expresión facial de las emociones y su relación con estilos de apego y síntomas psiquiátricos: Estudio preliminar en Residentes de Psiquiatría

Facial expressions of emotion reveal complex mental states that have physiological correlates and signal internal states such as distress to others and are thus crucial in social interaction. In this preliminary study, we therefore sought to examine the link between current psychiatric symptoms and attachment styles in psychiatry residents and their ability to correctly identify facial expressions of emotions. Specifically, we hypothesized that greater current psychiatric symptoms and insecure attachment would be related to difficulties in deciphering facial expressions of negative emotions. A total of 56 psychiatry residents were included in the study, together with 50 university students pursuing careers unrelated to mental health. In order to evaluate the subjects' psychiatric symptoms, the Checklist (SCL-90) and Attachment Styles Questionnaire (ASQ) were used and in order to examine the ability to recognize facial expressions of emotion, we chose the Pictures of Facial Affect (POFA). All the respondents gave their informed consent in writing. The control group recognized fear significantly less as compared to psychiatry residents. Among psychiatry residents, there was a significantly positive correlation between hostility and fear recognition and anxiety and fear recognition. The same was observed between obsessive-compulsive symptoms and disgust recognition. In the control group, there was a significantly negative correlation between paranoid ideation and phobic anxiety with sadness recognition. In resident psychiatry, happiness recognition was positively related to an attachment-style based on confidence, while sadness recognition and surprise recognition correlated negatively with an attachment style based on considering relationships as being of secondary importance. This is one of the first studies to examine emotion recognition skills in medical professionals, and the association of this ability with psychiatric symptoms and attachment styles. We think it is important to observe longitudinally what the possible relevance of these findings might be for both diagnostic accuracy and therapeutic relationships.

La expresión facial de las emociones revela estados mentales complejos que tienen correlatos fisiológicos y señales de estados internos, como la angustia, y que son esenciales en la interacción social. En el presente estudio preliminar examinamos la asociación entre los síntomas psiquiátricos, los estilos de apego y la habilidad para reconocer correctamente la expresión facial de las emociones básicas, en residentes de psiquiatría de una institución de salud mental de México. La hipótesis es que los síntomas psiquiátricos y el estilo de apego inseguro pueden estar relacionados con una dificultad para descifrar la expresión facial de emociones negativas. Un total de 56 residentes de psiquiatría fueron incluidos en el estudio junto con 50 estudiantes universitarios de la Universidad Nacional Autónoma de México, UNAM, de carreras diferentes a las relacionadas con la salud mental. Se utilizaron los siguientes instrumentos: Los síntomas psiquiátricos se evaluaron con el SCL-90, traducido y validado al español, el Cuestionario de Estilos de Apego (ASQ) traducido y validado al español, y para el reconocimiento de la expresión facial de las emociones se usó el Instrumento de Ekman, denominado Pictures of Facial Affect (POFA). Previamente, todos los participantes dieron su consentimiento informado con la firma de aceptación para participar en el estudio. Los estudiantes del grupo control reconocieron menos el miedo que los residentes de psiquiatría. En los residentes hubo una correlación positiva entre la hostilidad y el reconocimiento del miedo y entre la ansiedad y el reconocimiento del miedo. Lo mismo se observó entre los síntomas obsesivos-compulsivos y el reconocimiento del disgusto. En el grupo control se encontró una correlación negativa entre la ideación paranoide y la ansiedad fóbica con el reconocimiento de la tristeza. En los residentes el reconocimiento de la felicidad se relacionó positivamente con el estilo de apego basado en la confianza, mientras que el reconocimiento del miedo y la sorpresa fueron negativamente relacionados con el estilo de apego basado en considerar las relaciones como secundarias. Este es un primer estudio que examina la habilidad de reconocer las emociones básicas en profesionales de la medicina que están siendo entrenados en la especialidad de psiquiatría, y la relación con síntomas psiquiátricos y estilos de apego. Consideramos importante el estudio de estos factores a lo largo de la formación, por la posible relevancia que estos hallazgos puedan tener para el adecuado diagnóstico y la relación terapéutica.